TNF Pharmaceuticals
TNFA
NASDAQ
IPO2021
about TNFA
TNF Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for various cancers, including solid tumors and hematologic malignancies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.76 | $8.94 | $4.20 | $6.48M | 59.10M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.18 | n/a | n/a | 0% | 0% | 0% |